Insight on First approved COVID-19 vaccine Sputnik V
Posted on11 Aug 2020
Comments0
Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V is developed... Read More
Novavax and Serum Institute of India – licensing agreement for Development and Commercial Collaboration
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a license agreement with Serum Institute of... Read More
Novavax reports positive results from phase 1 trial of COVID-19 vaccine candidate, NVX-CoV2373 with Matrix-M
Novavax, a late-stage biotechnology company, announced phase 1 data from its phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID-19 vaccine with... Read More
Lupin gets exclusive rights to market and distribute 2 complex injectable assets from ForDoz Pharma
Pharma major Lupin Limited announced that its US based wholly-owned subsidiary Lupin Pharmaceuticals Inc., has entered into an agreement with ForDoz Pharma... Read More
Biotricity receives US FDA 510(k) clearance for Bioflux software II system
Biotricity, a medical diagnostic and consumer healthcare technology company, announced that it has received a 510(k) clearance from the FDA for its... Read More
Cofsils brand expansion with face masks launch
Cofsils, a leading brand under Cipla Health Ltd., which offers a complete solution for sore throat and cough related issues, has launched... Read More
Zydus Cadila’s ZyCoV-D in Phase II clinical trials for COVID-19
Zydus Cadila’s ZyCoV-D is the plasmid DNA vaccine to prevent COVID-19. ZyCoV-D was found to be safe and well tolerated in the... Read More